Ovarian neoplasm
MONDO:0021068A benign, borderline, or malignant neoplasm involving the ovary.
Also known as: neoplasm of ovary, neoplasm of the ovary, ovarian neoplasm, ovarian tumor, ovarian tumors, ovarian tumour, ovarian tumours, ovary neoplasm
2516 clinical trials for this condition and its sub-types, 78 tagged with Ovarian neoplasm itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Ovarian neoplasm
-
Ovarian cancer 1,004 trials · 1,200 incl. sub-types
11 sub-types
- Malignant epithelial tumor of ovary 8 trials · 656 incl. sub-types Sub-types →
- Malignant non-epithelial tumor of ovary 1 trial · 9 incl. sub-types Sub-types →
- Familial ovarian cancer 1 trial · 8 incl. sub-types Sub-types →
- Ovarian neuroendocrine neoplasm 0 trials · 2 incl. sub-types Sub-types →
- Ovarian sarcoma 0 trials · 2 incl. sub-types Sub-types →
- Malignant ovarian cyst 1 trial
- Ovarian Wilms tumor 0 trials
- Ovarian adenosarcoma 0 trials
- Ovarian endometrioid adenocarcinofibroma 0 trials
- Ovarian lymphoma 0 trials
- Ovarian malignant mesothelioma 0 trials
-
Ovarian epithelial tumor 14 trials · 664 incl. sub-types
11 sub-types
- Malignant epithelial tumor of ovary 8 trials · 656 incl. sub-types Sub-types →
- Ovarian serous tumor 6 trials · 208 incl. sub-types Sub-types →
- Ovarian clear cell tumor 7 trials · 57 incl. sub-types Sub-types →
- Borderline epithelial tumor of ovary 6 trials · 16 incl. sub-types Sub-types →
- Ovarian mucinous neoplasm 1 trial · 16 incl. sub-types Sub-types →
- Ovarian seromucinous tumor 1 trial · 14 incl. sub-types Sub-types →
- Ovarian Brenner tumor 3 trials · 5 incl. sub-types Sub-types →
- Ovarian papillary tumor 0 trials · 2 incl. sub-types Sub-types →
- Ovarian squamous cell neoplasm 0 trials · 2 incl. sub-types Sub-types →
- Ovarian adenoma benign 0 trials Sub-types →
- Ovarian mucinous adenofibroma 0 trials Sub-types →
-
Ovarian germ cell tumor 9 trials · 13 incl. sub-types
4 sub-types
- Malignant germ cell tumor of ovary 2 trials · 4 incl. sub-types Sub-types →
- Ovarian teratoma 0 trials · 3 incl. sub-types Sub-types →
- Pediatric ovarian germ cell tumor 0 trials · 2 incl. sub-types Sub-types →
- Ovarian cystic teratoma 0 trials Sub-types →
-
Ovarian sex cord-stromal tumor 1 trial · 7 incl. sub-types
6 sub-types
- Malignant sex cord stromal tumor of ovary 0 trials · 5 incl. sub-types Sub-types →
- Ovarian granulosa cell tumor 2 trials · 5 incl. sub-types Sub-types →
- Ovarian sertoli-stromal cell tumor 0 trials · 1 incl. sub-types Sub-types →
- Benign ovarian sex cord-stromal tumor 0 trials Sub-types →
- Ovarian gynandroblastoma 0 trials
- Ovarian thecoma 0 trials
-
Ovarian benign neoplasm 1 trial
15 sub-types
- Meigs syndrome 0 trials
- Atypical Meigs syndrome 0 trials
- Benign ovarian mucinous tumor 0 trials
- Benign ovarian sex cord-stromal tumor 0 trials Sub-types →
- Benign struma ovarii 0 trials
- Ovarian adenoma benign 0 trials Sub-types →
- Ovarian clear cell adenofibroma 0 trials Sub-types →
- Ovarian endometrioid adenofibroma 0 trials Sub-types →
- Ovarian fibroma 0 trials
- Ovarian mucinous adenofibroma 0 trials Sub-types →
- Ovarian serous adenofibroma 0 trials Sub-types →
- Ovarian surface papilloma 0 trials
- Pseudo-Meigs syndrome 0 trials
- Rete ovarii cystadenofibroma 0 trials
- Serous or mucinous cystadenoma of childhood 0 trials Sub-types →
-
Ovarian melanoma 0 trials
-
Rete ovarii neoplasm 0 trials
3 sub-types
- Rete ovarii adenocarcinoma 0 trials
- Rete ovarii adenoma 0 trials Sub-types →
- Rete ovarii cystadenofibroma 0 trials
Most studied deeper sub-types
-
Can engineered immune cells outsmart Drug-Resistant ovarian cancer?
Cure OngoingThis phase 1 trial tests an experimental therapy called AB-1015 in people with ovarian, fallopian tube, or primary peritoneal cancer that has stopped responding to platinum-based chemotherapy. AB-1015 uses a patient's own T cells, which are genetically engineered to recognize and…
Phase 1 • Sponsor: Arsenal Biosciences, Inc. • Aim: Cure
Last updated Sep 05, 2026 00:00 UTC
-
Can a new drug target Hard-to-Treat kidney and ovarian cancers?
Disease control OngoingThis trial tests an experimental drug called DS-6000a (also known as R-DXd) in people with advanced renal cell carcinoma (kidney cancer) and ovarian tumors. The main goals are to find a safe dose, identify side effects, and see if the drug can shrink tumors. Participants receive …
Phase 1 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New drug targets rare cancer mutation in early trial
Disease control OngoingThis early-phase study tests a new oral drug, ATV-1601, in people with advanced solid tumors or certain breast cancers that have a specific AKT1 E17K mutation. The main goals are to check safety, find the right dose, and see how the drug moves through the body. About 134 adults w…
Phase 1 • Sponsor: Atavistik Bio, Inc • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Experimental drug targets HER2-Positive tumors in multiple cancers
Disease control OngoingThis phase 2 trial tests an experimental drug called disitamab vedotin in people with advanced head and neck, lung, endometrial, or ovarian cancers that have a protein called HER2. The drug is designed to stick to cancer cells and kill them. Researchers want to see if it shrinks …
Phase 2 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Personalized vaccine plus chemo cocktail aims to outsmart advanced ovarian cancer
Disease control CancelledThis trial tests whether adding a personalized vaccine and immune-boosting drugs to standard chemotherapy can help the body fight advanced ovarian cancer more effectively. Participants receive chemotherapy directly into the abdomen along with oral medication and injections of a v…
Phase 1/2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New pill targets hard-to-treat cancers with KRAS mutation
Disease control OngoingThis study tests an experimental drug called LY3537982 in people with advanced solid tumors that have a specific KRAS G12C mutation. The goal is to see if the drug is safe and shrinks tumors. About 540 participants with lung, colorectal, endometrial, ovarian, pancreatic, or bile …
Phase 1/2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Can freezing ovarian tissue help girls have babies later?
Disease control OngoingThis study offers girls from birth to age 17 the chance to freeze their ovarian tissue before medical treatments that could harm their fertility, such as chemotherapy or radiation. The tissue is removed surgically and stored. Later, if they want to have children, the tissue can b…
Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
Ovarian cancer hope: new antibody combo aims to delay disease worsening
Disease control OngoingThis Phase 3 trial tests whether adding an experimental antibody called oregovomab to standard chemotherapy (paclitaxel and carboplatin) helps people with newly diagnosed advanced ovarian cancer live longer without their cancer getting worse. About 615 participants who had surger…
Phase 3 • Sponsor: CanariaBio Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Heated chemotherapy during surgery may delay ovarian cancer return
Disease control OngoingThis phase 3 trial tests whether giving heated chemotherapy directly into the abdomen during surgery can help people with advanced ovarian cancer live longer without the disease coming back. About 362 participants will either receive standard surgery alone or surgery plus the hea…
Phase 3 • Sponsor: Centre Oscar Lambret • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New pill may keep ovarian cancer at bay after chemo
Disease control OngoingThis study tests whether a daily pill called niraparib can help keep advanced ovarian cancer from coming back after initial chemotherapy. About 733 women with stage III or IV ovarian cancer who responded to platinum-based chemo took either niraparib or a placebo. The main goal wa…
Phase 3 • Sponsor: Tesaro, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New drug cocktail shows promise in battle against advanced ovarian cancer
Disease control OngoingThis study tests whether adding two newer drugs (dostarlimab and niraparib) to standard chemotherapy helps people with advanced ovarian cancer live longer without their cancer growing. About 1,400 participants with stage III or IV ovarian cancer will receive either the standard t…
Phase 3 • Sponsor: Tesaro, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New drug BT8009 targets Hard-to-Treat cancers in early trial
Disease control OngoingThis study tests a new drug called BT8009, alone or with another drug (pembrolizumab), in people with advanced solid tumors like bladder, breast, lung, or ovarian cancer. The drug targets a protein called Nectin-4 found on some cancer cells. The trial aims to find safe doses and …
Phase 1/2 • Sponsor: BicycleTx Limited • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Ovarian cancer vaccine trial aims to keep tumors at bay
Disease control OngoingThis study tests a personalized immunotherapy called Vigil in 92 women with advanced ovarian cancer who are currently cancer-free after surgery and chemotherapy. The treatment uses the patient's own tumor cells to create a vaccine that trains the immune system to fight any remain…
Phase 2 • Sponsor: Gradalis, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New online tool aims to clear up confusion around cancer screening
Knowledge-focused CancelledThis study aimed to create a web-based decision aid for people invited to cancer screening in Sweden. The tool would provide clear information about the benefits and harms of screening, helping individuals decide based on knowledge rather than fear. The study was withdrawn before…
Sponsor: Karolinska Institutet • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
DNA bank aims to unlock secrets of family cancer clusters
Knowledge-focused OngoingThis study collects blood and saliva samples from people with cancer and their relatives to build a DNA bank. Researchers hope to better understand how cancer runs in families. About 992 participants are expected to join. The samples will be stored and analyzed later for genetic …
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC